1. Home
  2. CTMX vs BRIA Comparison

CTMX vs BRIA Comparison

Compare CTMX & BRIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • BRIA
  • Stock Information
  • Founded
  • CTMX 2008
  • BRIA 2011
  • Country
  • CTMX United States
  • BRIA Singapore
  • Employees
  • CTMX N/A
  • BRIA N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • BRIA
  • Sector
  • CTMX Health Care
  • BRIA
  • Exchange
  • CTMX Nasdaq
  • BRIA NYSE
  • Market Cap
  • CTMX 85.3M
  • BRIA 86.3M
  • IPO Year
  • CTMX 2015
  • BRIA 2024
  • Fundamental
  • Price
  • CTMX $0.79
  • BRIA $3.10
  • Analyst Decision
  • CTMX Buy
  • BRIA
  • Analyst Count
  • CTMX 6
  • BRIA 0
  • Target Price
  • CTMX $5.77
  • BRIA N/A
  • AVG Volume (30 Days)
  • CTMX 814.8K
  • BRIA 30.7K
  • Earning Date
  • CTMX 03-10-2025
  • BRIA 02-19-2025
  • Dividend Yield
  • CTMX N/A
  • BRIA N/A
  • EPS Growth
  • CTMX N/A
  • BRIA N/A
  • EPS
  • CTMX 0.16
  • BRIA 92.24
  • Revenue
  • CTMX $126,617,000.00
  • BRIA $55,755,669.00
  • Revenue This Year
  • CTMX $22.55
  • BRIA N/A
  • Revenue Next Year
  • CTMX N/A
  • BRIA N/A
  • P/E Ratio
  • CTMX $4.85
  • BRIA $0.03
  • Revenue Growth
  • CTMX 33.66
  • BRIA 8.03
  • 52 Week Low
  • CTMX $0.78
  • BRIA $2.90
  • 52 Week High
  • CTMX $5.85
  • BRIA $4.38
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 39.47
  • BRIA N/A
  • Support Level
  • CTMX $0.82
  • BRIA N/A
  • Resistance Level
  • CTMX $0.98
  • BRIA N/A
  • Average True Range (ATR)
  • CTMX 0.07
  • BRIA 0.00
  • MACD
  • CTMX 0.00
  • BRIA 0.00
  • Stochastic Oscillator
  • CTMX 6.67
  • BRIA 0.00

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About BRIA BRILLIA INC

BrilliA Inc is engaged in business of sales and marketing of lingerie's products including bra, panty and body suit, mainly serving the American, European and other markets.

Share on Social Networks: